| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 3.98163 | 15 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 3.61165 | 6 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 4.72714 | 35 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 3.71353 | 8 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 3.93286 | 14 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 3.82135 | 12 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 4.13117 | 20 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 3.59543 | 5 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 3.81053 | 10 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 3.65967 | 7 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 3.62696 | 6 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 3.73372 | 9 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 3.81821 | 11 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 4.05951 | 19 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 3.7647 | 10 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 3.75722 | 10 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 3.86793 | 14 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 4.35784 | 26 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 4.09492 | 19 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 4.97517 | 37 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 3.68031 | 7 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 3.86551 | 13 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 3.75634 | 10 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 3.81969 | 11 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 3.61501 | 6 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 4.25669 | 24 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 3.76379 | 9 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.02 | 16 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 3.80138 | 10 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 3.86217 | 11 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 3.75051 | 10 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 4.03053 | 18 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 3.64562 | 6 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 3.73581 | 9 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 4.54521 | 31 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 4.31384 | 26 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 3.83409 | 11 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 3.85119 | 12 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 3.73039 | 8 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 5.98327 | 58 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 3.59298 | 5 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 4.29112 | 23 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 7.79586 | 79 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 4.08326 | 20 |